,,ii  #aagth ,,congress  #b;d ,session  
,s4 #dcda  ,,in ,,the ,,senate ,,of     
,,the ,,united ,,states  ,may #bf1      
#bjbb,ms4 ,rosen 7for herself and ,mr4  
,romney7 introduced the following bill2 
which was read twice and referred to the
 ,committee on ,health1 ,education1     
,labor1 and ,pensions  ,a ,,bill  ,to   
require the ,government ,accountability 
,office to issue a report on nonprofit  
pharmaceutical organizations4  #a4      
,short title ,this ,act may be cited as 
the ,advancing ,affordable ,medicines   
for ,families ,act4  #b4 ,,gao report on
 nonprofit pharmaceutical organizations 
,the ,comptroller ,general of the       
,united ,states shall submit a report to
 ,congress on the following3 7#a7 ,the  
potential impact of nonprofit           
pharmaceutical organizations on the     
availability and cost of drugs1         
including on drug shortages1 consumer   
costs1 and costs to ,federal programs4  
7#b7 ,the potential of nonprofit        
pharmaceutical organizations to         

accelerate development of new drugs1    
generic drugs1 new biological products1 
biosimilar biological products1         
cell-based therapies1 and devices4  7#c7
 ,existing barriers to the success of   
nonprofit pharmaceutical organizations1 
including the ability of such           
organizations to obtain tax-exempt      
status1 access to capital1 and access to
 markets4  7#d7 ,potential actions by   
,congress that would allow nonprofit    
pharmaceutical organizations to deliver 
benefits to the pharmaceutical market4